Immune Checkpoint Inhibition for Unresectable Malignant Pleural Mesothelioma Wanyuan CuiSanjay Popat Current Opinion 09 June 2021 Pages: 971 - 984
Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis Tamara Pérez-JeldresManuel Alvarez-LobosJesús Rivera-Nieves Leading Article Open access 13 May 2021 Pages: 985 - 1002
A Pharmacological and Clinical Overview of Oral Semaglutide for the Treatment of Type 2 Diabetes Andreas AndersenFilip Krag KnopTina Vilsbøll Review Article Open access 08 May 2021 Pages: 1003 - 1030
Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015–2020 Niklas HuntemannLeoni RolfesSven G. Meuth Review Article Open access 04 June 2021 Pages: 1031 - 1063
Antimicrobial Lessons From a Large Observational Cohort on Intra-abdominal Infections in Intensive Care Units Dirk VogelaersStijn Blotfor the Abdominal Sepsis Study (‘AbSeS’) Group on behalf of the Trials Group of the European Society of Intensive Care Medicine Review Article 26 May 2021 Pages: 1065 - 1078
A Multicentric, Randomized, Controlled Phase III Study of Centhaquine (Lyfaquin®) as a Resuscitative Agent in Hypovolemic Shock Patients Anil GulatiRajat ChoudhuriNilesh Radheshyam Agrawal Original Research Article Open access 01 June 2021 Pages: 1079 - 1100
Lazertinib: First Approval Sohita Dhillon AdisInsight Report Open access 24 May 2021 Pages: 1107 - 1113
Comment on: “Post-Dialysis Parenteral Antimicrobial Therapy in Patients Receiving Intermittent High-Flux Haemodialysis” Eric DescombesOuld Maouloud HemettChristian Chuard Letter to the Editor 26 May 2021 Pages: 1121 - 1123
Comment on: “Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry” Alpo VuorioPetri T. Kovanen Letter to the Editor 28 May 2021 Pages: 1125 - 1127
Correction to: Inclisiran: First Approval Yvette N. Lamb Correction Open access 13 May 2021 Pages: 1129 - 1129
Correction to: Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer Diego Kauffmann-GuerreroKathrin KahnertRudolf M. Huber Correction Open access 26 May 2021 Pages: 1131 - 1131
Correction to: Nintedanib: A Review in Fibrotic Interstitial Lung Diseases Yvette N. Lamb Correction Open access 29 May 2021 Pages: 1133 - 1133